TECHLAB(R) Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK(TM) To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite

E. HISTOLYTICA QUIK CHEK™ and GIARDIA/CRYPTOSPORIDIUM QUIK CHEK™ Provide a definitive diagnosis in parasite screening

BLACKSBURG, Va., June 13, 2017 -- (Healthcare Sales & Marketing Network) -- TECHLAB,® Inc., a leading developer and manufacturer o... Diagnostics, FDA TECHLAB, E. HISTOLYTICA QUIK CHEK, Amebiasis, E. Histolytica

Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news